Gossamer Bio, Inc.GOSSNASDAQ
Loading
R&D Expenses Over TimeExpanding
Percentile Rank100
3Y CAGR+2.0%
5Y CAGR+2.8%
Year-over-Year Change
Research and development spending
3Y CAGR
+2.0%/yr
vs +32.6%/yr prior
5Y CAGR
+2.8%/yr
Consistent
Acceleration
-30.6pp
Decelerating
Percentile
P100
Near historical high
vs 5Y Ago
1.1x
Modest growth
Streak
2 yr
Consecutive growthExpanding
| Period | Value | YoY Change |
|---|---|---|
| TTM | $181.56M | +31.1% |
| 2024 | $138.49M | +2.4% |
| 2023 | $135.30M | -20.8% |
| 2022 | $170.92M | +0.4% |
| 2021 | $170.27M | +7.8% |
| 2020 | $158.00M | +10.2% |
| 2019 | $143.40M | +159.4% |
| 2018 | $55.28M | +6104.6% |
| 2017 | $891000.00 | - |
| 2016 | $0.00 | - |